In vivo genotoxic evaluation of the furylethylene derivative 1-(5-bromofur-2-yl)-2-nitroethene in mouse bone marrow

Environmental Toxicology and Pharmacology

Volumn 20, Issue 1, 2005, Pages 241-245

  González Borroto, Jorge I ^a,b   Creus, Amadeu ^a   Marcos, Ricard ^a   Zapatero, Jorge ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

1 (5 Bromofur 2 yl) 2 nitroethene; Bone marrow; CD 1 mice; Micronucleated erythrocytes

Indexed keywords

1 (5 BROMOFUR 2 YL) 2 NITROETHENE; CYCLOPHOSPHAMIDE; ETHYLENE DERIVATIVE; FURYLETHYLENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BONE MARROW CELL; CELL COUNT; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DOSE CALCULATION; DYSPNEA; ERYTHROCYTE SHAPE; GENOTOXICITY; IN VIVO STUDY; IRRITABILITY; MALE; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PTOSIS;

ANIMALIA; ATAXIA; CUCURBITA;

EID: 18144377028     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2005.02.003     Document Type: Article

References (24)

1. J.M. Blondeau, N. Castañedo, O. González, R. Medina, and E. Silveira In vitro evaluation of G1: a novel antimicrobial compound Int. J. Antimicrob. Agents 11 1999 163 166
2. Castañedo, N., Goizueta, R., Pérez, J., González, J., Silveira, E., Cuesta, M., Martínez, A., Lugo, E., Estrada, E., Carta, A.C., Navia, O., Delgado, M.S., 1994. Procedure for the Obtainment of 1-(5-Bromofur-2-yl)-2-Bromo-2-Nitroethene and its Microcide Action, Cuban Patent 22446. European Patent, Application Number 95500056.7. Canadian Patent, Application Number 2,147,594. Japanese Patent, Application Number 222002. U.S. Patent, Application Number 60008011.
3. D.K. Dalvie, A.S. Kalgutkar, C.S. Khojasteh-Bakht, R.S. Scott Obach, and J.P. O'Donnell Biotransformation reactions of five-membered aromatic heterocyclic rings Chem. Res. Toxicol. 15 2002 269 299
4. A.K. Debnath, C. Hansch, K.H. Kim, and Y.C. Martin Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysis J. Med. Chem. 36 1993 1007 1016
5. E. Estrada Structure-mutagenicity relationships in 2-furylethylene derivatives. A molecular orbital study of the role of nitro groups Mutat. Res. 420 1998 67 75
6. European Union, 2000. Commission Directive 2000/32/EC, Annex 4C, Off. J. Eur. Community 136, 50-56.
7. J.I. González Borroto, A. Creus, and R. Marcos Genotoxic evaluation of the furylethylene derivative 2-furyl-1-nitroethene in cultured human lymphocytes Mutat. Res. 497 2001 177 184
8. J.I. González Borroto, A. Creus, and R. Marcos Genotoxic evaluation of the furylethylene derivative 1-(5-bromofur-2-yl)-2-nitroethene in cultured human lymphocytes Mutat. Res. 519 2002 179 185
9. J.I. González Borroto, A. Creus, R. Marcos, R. Mollà, and J. Zapatero Genotoxic potential of the furylethylene derivative 2-furyl-1-nitroethene in the mouse bone marrow micronucleus test Toxicol. Sci. 72 2003 359 362
10. J.I. González Borroto, G. Peréz, A. Creus, and R. Marcos Genotoxicity testing of the furylethylene derivative 1-(5-bromofur-2-yl)-2- bromo-2-nitroethene in cultured human lymphocytes Food Chem. Toxicol. 42 2004 187 193
11. J.M.T. Hamilton-Miller Nitrofurans F. O'Grady H.P. Lambert R.G. Finch D. Greenwood Antibiotic and Chemotherapy seventh ed. 1997 Churchill Livingstone London 396 403
12. J.F. Hatcher, K. Yamamoto, M. Ichikawa, G.T. Bryan, and S. Swaminathan Metabolic reduction of novel 3,4-dichloro-5-nitrofurans in Salmonella typhimurium Environ. Mol. Mutagen. 25 1995 58 66
13. ICH, 1995. Topic S2A Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals. ICH, Harmonised Tripartite Guideline, pp. 1-12.
14. G. Krishna, and M. Hayashi In vivo rodent micronucleus assay: protocol, conduct and data interpretation Mutat. Res. 455 2000 155 166
15. G. Krishna, G. Urda, and J. Paulissen Historical vehicle and positive control micronucleus data in mice and rats Mutat. Res. 453 2000 45 50
16. D.R. McCalla Mutagenicity of nitrofuran derivatives: review Environ. Mutagen. 5 1983 745 765
17. F.C. Meotti, D. Silva, A.R.S. dos Santos, G. Zeni, J.B.T. Rocha, and C.W. Nogueira Thiophenes and furans derivatives: a new class of potential pharmacological agents Environ. Toxicol. Pharmacol. 37 2003 37 44
18. Monzote, L., Sifontes, S., Montalvo, A.M., 1999. Evaluación de la actividad terapéutica de dos principios activos frente a Leishmaniosis cutánea experimental. Tesis de Grado de Farmacia (FAL), Universidad de La Habana.
19. OECD, 1997. Guideline 474, Mammalian Erythrocyte Micronucleus Test, OECD Guideline for the Testing of Chemicals. OECD, Paris, France, pp. 1-10.
20. A. Ramos, A. Vizoso, A. Edreira, J. Betancourt, and M. Decalo Activity of nitroalkene derivative 1-(5-bromofur-2-il)-2-bromo-2-nitroethene in Salmonella/microsome assay and the mouse bone marrow micronucleus test Mutat. Res. 390 1997 233 238
21. M.F. Salamone, and K.H. Mavournin Bone marrow micronucleus assay: a review of the mouse stocks used and their published mean spontaneous micronucleus frequencies Environ. Mol. Mutagen. 23 1994 239 273
22. H.R. Skeggs, R.M. Berglund, W.J.A. VandenHeuvel, H. Mrozik, P.G. Wislocki, and F.J. Wolf Effect of liver enzymes on the mutagenicity of nitroheterocyclic compounds: activation of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl- 5-nitro-1-H-imidazol-2-yl)-1,2-benzisoxazole and deactivation of nitrofurans and nitroimidazoles in the Ames test Mutat. Res. 136 1984 1 8
23. G. Slapsyte, A. Jankauskiene, J. Mierauskiene, and J.R. Lazutka Cytogenetic analysis of peripheral blood lymphocytes of children treated with nitrofurantoin for recurrent urinary tract infection Mutagenesis 1 2002 31 35
24. E. Sturdik, M. Rosenberg, L. Stibranyi, S. Balaz, O. Chreno, L. Ebringer, D. Ilavsky, and D. Vegh Structure-mutagenicity relationships of 5-nitro-2-furylethylenes in Salmonella typhimurium TA 98 Chem. Biol. Interact. 53 1985 145 153